SLE is a chronic autoimmune rheumatic disorder of high heterogeneity in clinical
presentation, treatment response and prognosis. Long-term outcomes in SLE have been …

Health care in systemic lupus erythematosus (SLE) is complex owing to the heterogenous
nature of the disease with diverse organ manifestations and unpredictable disease course …

Background Observational studies have indicated a potential association between
autoimmune diseases and the occurrence of sepsis, with an increased risk of mortality …

Background: Systemic lupus erythematosus (SLE) is an autoimmune disease. This study
aims to analyze the value of procalcitonin (PCT), white blood cell count (WBC), and …

Sepsis is a clinical syndrome with high mortality and morbidity rates. In sepsis, the abrupt
release of cytokines by the innate immune system may cause multiorgan failure, leading to …

Introduction/objectives Infections are a major cause of morbidity and death in systemic lupus
erythematosus (SLE). Perfecting the understanding of contributors to infection burden in SLE …

Systemic lupus erythematosus (SLE) is associated with higher risks of sepsis and sepsis-
related mortality compared to the general population. However, the prognostic impact of SLE …

Objectives: Patients with connective tissue diseases (CTD) such as systemic lupus
erythematosus (SLE) have an increased risk for infections. This study investigated the …

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a wide range of
clinical manifestations and a relapsing-remitting course. SLE pathogenesis is the result of …

Background Infectious disease is an increasing threat to patients with systemic lupus
erythematosus (SLE); however, the long-term outcome in critically ill septic patients with SLE …